Anyone over 16 can now receive a Covid booster vaccine
You can receive your booster 90 days following your first round. As of today (2 January), anyone over the age of 16 can receive a booster dose of a Covid vaccine. People who book an appointment for a booster vaccine will receive a single dose of Pfizer / BioNTech. Minister for Health Stephen Donnelly said […]
4 years ago
Three shots of Pfizer neutralises Omicron variant in laboratory test
4,152 cases of Covid were confirmed in Ireland on Wednesday. BioNTech and Pfizer have confirmed that a booster dose of their Covid vaccine neutralises the Omicron variant following a laboratory test. According to a statement on the Pfizer website, the effectiveness of protection from the Omicron variant increased by 25 times following a third dose. […]
4 years ago
Merck anti-Covid pill given green light for emergency use in Europe
The move was made in light of rising Covid rates across the EU. Pharmaceutical company Merck’s anti-covid pill has been given the green light for emergency use in EU countries by the European Medicines Agency (EMA). Though the pill, also known as molnupiravir, is not authorised in the EU yet, the EMA issued advice on […]
4 years ago
Pfizer’s Cork plant will produce its new Covid-19 pill if approved
The pharma giant says the pill cuts the risk of severe Covid by 89%. Pfizer has confirmed that its manufacturing facility in Ringaskiddy in Cork will support the global manufacturing and supply of its new Covid-19 pill, should it be approved. It comes as the pharma giant said on Friday (5 November) that its investigational […]
4 years ago
New Zealand reports its first death linked to Pfizer vaccine
The public has been reassured by the health ministry that the benefits of the Pfizer jab still greatly outweigh the risks. New Zealand has reported what it believes to be its first death linked to the Pfizer Covid-19 vaccine. The country’s health ministry said an independent Covid-19 vaccine safety monitoring board had concluded that the […]
4 years ago
Pfizer is seeking authorisation for a third dose of its Covid-19 vaccine
The company said early data showed that antibody levels jump five to 10-fold after a third dose. Pfizer and BioNTech have announced that they will seek regulatory approval for a third dose of their Covid-19 vaccine. It’s an attempt to boost the efficacy of its vaccine as the Delta variant becomes more prevalent across the world. Research […]
5 years ago